AKT1 and ovarian carcinoma: Simvastatin inhibited the PI3K/AKT pathway in SKOV3 and HEY cells, increased the active oxygen level to cause DNA damage, induced ER stress, and reduced the VEGF expression, thus playing an anti-proliferation and metastasis role in ovarian cancer (Stine et al., 2016).